$MYO
MYOMO, INC.

2022 Q4 Form 10-Q Financial Statement

#000095017022024522 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $4.042M $3.968M $4.384M
YoY Change 0.25% -9.48% 127.54%
Cost Of Revenue $1.414M $1.331M $1.110M
YoY Change 55.52% 19.91% 29.8%
Gross Profit $2.628M $2.637M $3.274M
YoY Change -15.85% -19.45% 205.58%
Gross Profit Margin 65.02% 66.45% 74.68%
Selling, General & Admin $4.357M $4.765M $4.663M
YoY Change -13.56% 2.2% 42.56%
% of Gross Profit 165.83% 180.71% 142.43%
Research & Development $499.7K $690.4K $641.2K
YoY Change -36.56% 7.67% 85.51%
% of Gross Profit 19.02% 26.18% 19.59%
Depreciation & Amortization $49.06K $49.09K $36.91K
YoY Change -3.35% 33.0% 38.19%
% of Gross Profit 1.87% 1.86% 1.13%
Operating Expenses $4.857M $5.456M $5.304M
YoY Change -16.66% 2.86% 46.67%
Operating Profit -$2.229M -$2.819M -$2.030M
YoY Change -17.61% 38.83% -20.23%
Interest Expense $39.74K $28.96K -$4.060K
YoY Change -873.15% -813.28% -90.14%
% of Operating Profit
Other Income/Expense, Net -$1.100K $12.31K -$4.055K
YoY Change -403.5% -98.24%
Pretax Income -$2.191M -$2.806M -$2.034M
YoY Change -19.19% 37.95% -26.7%
Income Tax -$23.27K $23.38K $22.70K
% Of Pretax Income
Net Earnings -$2.167M -$2.830M -$2.057M
YoY Change -20.7% 37.56% -25.92%
Net Earnings / Revenue -53.63% -71.31% -46.92%
Basic Earnings Per Share -$0.40 -$0.36
Diluted Earnings Per Share -$0.29 -$0.40 -$362.1K
COMMON SHARES
Basic Shares Outstanding 7.055M 7.000M 5.681M
Diluted Shares Outstanding 7.064M 5.681M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.346M $7.420M $12.61M
YoY Change -65.56% -41.14% -5.34%
Cash & Equivalents $5.346M $7.400M $12.61M
Short-Term Investments
Other Short-Term Assets $573.5K $553.7K $994.1K
YoY Change -35.89% -44.3% 25.79%
Inventory $1.400M $1.483M $644.1K
Prepaid Expenses
Receivables $1.896M $1.595M $2.216M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $9.215M $11.05M $16.46M
YoY Change -51.73% -32.86% 8.46%
LONG-TERM ASSETS
Property, Plant & Equipment $194.3K $240.0K $998.5K
YoY Change -29.43% -75.97% 845.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $132.5K $149.1K
YoY Change
Other Assets $111.0K $111.0K
YoY Change 16.47%
Total Long-Term Assets $946.5K $1.105M $998.5K
YoY Change -5.68% 10.68% 452.88%
TOTAL ASSETS
Total Short-Term Assets $9.215M $11.05M $16.46M
Total Long-Term Assets $946.5K $1.105M $998.5K
Total Assets $10.16M $12.16M $17.46M
YoY Change -49.43% -30.37% 13.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.323M $878.6K $624.4K
YoY Change 82.89% 40.72% 88.13%
Accrued Expenses $2.210M $3.212M $3.098M
YoY Change -37.91% 3.67% 73.06%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.602M $4.114M $3.723M
YoY Change -15.91% 10.5% 68.68%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $200.7K $221.6K $589.1K
YoY Change -50.18% -62.39% 251.96%
Total Long-Term Liabilities $200.7K $221.6K $589.1K
YoY Change -50.18% -62.39% 251.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.602M $4.114M $3.723M
Total Long-Term Liabilities $200.7K $221.6K $589.1K
Total Liabilities $3.803M $4.335M $4.312M
YoY Change -18.86% 0.54% 81.6%
SHAREHOLDERS EQUITY
Retained Earnings -$88.78M -$86.60M -$75.30M
YoY Change 13.68% 15.01%
Common Stock $95.11M $94.46M
YoY Change 1.68%
Preferred Stock
YoY Change
Treasury Stock (at cost) $6.464K $6.464K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $6.359M $7.822M $13.15M
YoY Change
Total Liabilities & Shareholders Equity $10.16M $12.16M $17.46M
YoY Change -49.43% -30.37% 13.69%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$2.167M -$2.830M -$2.057M
YoY Change -20.7% 37.56% -25.92%
Depreciation, Depletion And Amortization $49.06K $49.09K $36.91K
YoY Change -3.35% 33.0% 38.19%
Cash From Operating Activities -$2.464M -$2.799M -$2.210M
YoY Change 34.76% 26.66% 24.98%
INVESTING ACTIVITIES
Capital Expenditures $3.380K -$5.740K -$54.89K
YoY Change -114.12% -89.54% 144.94%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$3.380K -$5.740K -$54.89K
YoY Change -85.88% -89.54% 144.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 376.9K 0.000 1.099M
YoY Change -92.12% -100.0% -74.89%
NET CHANGE
Cash From Operating Activities -2.464M -2.799M -2.210M
Cash From Investing Activities -3.380K -5.740K -54.89K
Cash From Financing Activities 376.9K 0.000 1.099M
Net Change In Cash -2.091M -2.804M -1.166M
YoY Change -171.43% 140.53% -145.11%
FREE CASH FLOW
Cash From Operating Activities -$2.464M -$2.799M -$2.210M
Capital Expenditures $3.380K -$5.740K -$54.89K
Free Cash Flow -$2.468M -$2.793M -$2.155M
YoY Change 36.74% 29.62% 23.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001369290
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38109
dei Entity Registrant Name
EntityRegistrantName
MYOMO, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-0944526
dei Entity Address Address Line1
EntityAddressAddressLine1
137 Portland St.
dei Entity Address Address Line2
EntityAddressAddressLine2
4th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02114
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
996-9058
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
MYO
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7054875
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7420020
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15524378
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1595266
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1960037
CY2022Q3 us-gaap Inventory Net
InventoryNet
1482935
CY2021Q4 us-gaap Inventory Net
InventoryNet
808308
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
553696
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
799164
CY2022Q3 us-gaap Assets Current
AssetsCurrent
11051917
CY2021Q4 us-gaap Assets Current
AssetsCurrent
19091887
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
604960
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
632906
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
239955
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
275289
CY2022Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
149140
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
111034
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
95330
CY2022Q3 us-gaap Assets
Assets
12157006
CY2021Q4 us-gaap Assets
Assets
20095412
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3649085
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3949784
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
441386
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
333380
CY2022Q3 us-gaap Deferred Income Current
DeferredIncomeCurrent
23053
CY2021Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
249
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4113524
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4283413
CY2022Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
685
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1246
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
220901
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
401622
CY2022Q3 us-gaap Liabilities
Liabilities
4335110
CY2021Q4 us-gaap Liabilities
Liabilities
4686281
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
65000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
65000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7053023
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6869753
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7052996
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6869726
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
706
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
687
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
94454914
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
93537807
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11466
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-60677
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86615794
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-78062222
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
27
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
27
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
6464
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
6464
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7821896
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15409131
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12157006
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20095412
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3968201
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4383957
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11513702
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9824740
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
1331217
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
1110204
us-gaap Cost Of Revenue
CostOfRevenue
3888217
us-gaap Cost Of Revenue
CostOfRevenue
2634922
CY2022Q3 us-gaap Gross Profit
GrossProfit
2636984
CY2021Q3 us-gaap Gross Profit
GrossProfit
3273753
us-gaap Gross Profit
GrossProfit
7625485
us-gaap Gross Profit
GrossProfit
7189818
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
690407
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
641228
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1982815
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1769739
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4765218
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4662796
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14085523
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12982413
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
5455625
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
5304024
us-gaap Operating Expenses
OperatingExpenses
16068338
us-gaap Operating Expenses
OperatingExpenses
14752152
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2818641
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2030271
us-gaap Operating Income Loss
OperatingIncomeLoss
-8442853
us-gaap Operating Income Loss
OperatingIncomeLoss
-7562334
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
28959
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4055
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
32343
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-10193
CY2022Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-16652
us-gaap Gain Loss On Investments
GainLossOnInvestments
-49860
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12307
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4055
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17517
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10193
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2806334
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2034326
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8460370
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7572527
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23382
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22696
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
93202
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
66604
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2829716
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2057022
us-gaap Net Income Loss
NetIncomeLoss
-8553572
us-gaap Net Income Loss
NetIncomeLoss
-7639131
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7064188
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7064188
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5681121
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5681121
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6880918
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6880918
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5530259
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5530259
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.38
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2829716
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2057022
us-gaap Net Income Loss
NetIncomeLoss
-8553572
us-gaap Net Income Loss
NetIncomeLoss
-7639131
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1617
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8285
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
49211
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2181
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1617
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8285
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
49211
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2181
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2831333
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2065307
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8504361
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7636950
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15409131
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
266270
CY2022Q1 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
9245
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2814934
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
12869712
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
345223
CY2022Q2 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
41583
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2908922
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10347596
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
305633
CY2022Q3 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
-1617
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2829716
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7821896
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11565374
CY2021Q1 myo Common Stock Issued For Warrants Exercised
CommonStockIssuedForWarrantsExercised
7288275
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
165971
CY2021Q1 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
8323
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2960794
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
16067149
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
363312
CY2021Q2 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
2143
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2621315
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
13811289
CY2021Q3 myo Proceeds From Issuances Under At Market Sales Facility Value
ProceedsFromIssuancesUnderAtMarketSalesFacilityValue
1099801
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
301763
CY2021Q3 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
-8285
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2057022
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
13147546
us-gaap Profit Loss
ProfitLoss
-8553572
us-gaap Profit Loss
ProfitLoss
-7639131
us-gaap Depreciation
Depreciation
143742
us-gaap Depreciation
Depreciation
95238
us-gaap Share Based Compensation
ShareBasedCompensation
917126
us-gaap Share Based Compensation
ShareBasedCompensation
831046
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
26075
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-202
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
253611
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
126529
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
-49860
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-99771
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-463
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-362759
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1281989
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
752720
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-52734
myo Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-240050
myo Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
422881
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
15705
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-264182
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
577238
myo Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-298380
myo Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-51462
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
22244
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2512
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4637
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7769321
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7719162
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
199000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
108408
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
302527
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-307408
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-302527
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
7288275
myo Proceeds From At The Market Offering Net Of Offering Costs
ProceedsFromAtTheMarketOfferingNetOfOfferingCosts
0
myo Proceeds From At The Market Offering Net Of Offering Costs
ProceedsFromAtTheMarketOfferingNetOfOfferingCosts
1099801
myo Proceeds From Payments Under Grants
ProceedsFromPaymentsUnderGrants
0
myo Proceeds From Payments Under Grants
ProceedsFromPaymentsUnderGrants
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8388076
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-27629
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-890
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8104358
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
365497
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15524378
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12241261
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7420020
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12606758
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
225665
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
654091
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
50000
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
5
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0
us-gaap Nature Of Operations
NatureOfOperations
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note 1 — Description of Business</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Myomo Inc. (“Myomo” or the Company”) is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro ® myoelectric upper limb orthosis product is registered with the U.S. Food and Drug Administration as a Class II medical device. The Company sells its products directly to patients, to orthotics and prosthetics (O&amp;P) providers around the world, the Veterans Health Administration, and distributors in Europe and Australia.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company was incorporated in the State of Delaware on September 1, 2004 and is headquartered in Boston, Massachusetts.</span></p>
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7400000
us-gaap Net Income Loss
NetIncomeLoss
-8600000
us-gaap Net Income Loss
NetIncomeLoss
-7600000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-86600000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7800000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7700000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain prior year amounts in prepaid expenses and other current assets have been reclassified to other assets to conform with the current year presentation.</span></p>
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0
CY2022Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0
CY2021Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
0
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America require management to make estimates and assumptions that affect certain reported amounts and disclosures. These estimates and assumptions are reviewed on an on-going basis and updated as appropriate. Actual results could differ from these estimates. The Company’s significant estimates include the allowance for doubtful accounts, deferred tax valuation allowances, valuation of stock-based compensation, warranty obligations and reserves for slow-moving inventory.</span></p>
CY2022Q3 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
26000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0
CY2022Q3 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
CY2022Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-16652
us-gaap Gain Loss On Investments
GainLossOnInvestments
-49860
CY2022Q3 myo Percentage Of Direct Billing Channel Revenue Insures Represent
PercentageOfDirectBillingChannelRevenueInsuresRepresent
0.41
CY2021Q3 myo Percentage Of Direct Billing Channel Revenue Insures Represent
PercentageOfDirectBillingChannelRevenueInsuresRepresent
0.38
myo Percentage Of Direct Billing Channel Revenue Insures Represent
PercentageOfDirectBillingChannelRevenueInsuresRepresent
0.43
myo Percentage Of Direct Billing Channel Revenue Insures Represent
PercentageOfDirectBillingChannelRevenueInsuresRepresent
0.38
CY2022Q3 us-gaap Deferred Revenue
DeferredRevenue
23700
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
1500
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3968201
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4383957
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11513702
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9824740
CY2022Q3 us-gaap Advertising Expense
AdvertisingExpense
1048200
CY2021Q3 us-gaap Advertising Expense
AdvertisingExpense
916900
us-gaap Advertising Expense
AdvertisingExpense
3037800
us-gaap Advertising Expense
AdvertisingExpense
2526000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1211854
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2044626
us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount1
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1
-640000
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
485376
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
176082
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
17718
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
23161
CY2022Q3 myo Inventory Rental Units
InventoryRentalUnits
51694
CY2021Q4 myo Inventory Rental Units
InventoryRentalUnits
62531
CY2022Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
970329
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
584996
CY2022Q3 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1525117
CY2021Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
846770
CY2022Q3 myo Inventory Reserve For Rental Units
InventoryReserveForRentalUnits
42182
CY2021Q4 myo Inventory Reserve For Rental Units
InventoryReserveForRentalUnits
38462
CY2022Q3 us-gaap Inventory Net
InventoryNet
1482935
CY2021Q4 us-gaap Inventory Net
InventoryNet
808308
CY2022Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
213253
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
176281
CY2022Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
6322815
CY2021Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
14803456
CY2022Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
878600
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
723352
CY2022Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1168132
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2188869
CY2022Q3 myo Professional Fees Accrued Current
ProfessionalFeesAccruedCurrent
89032
CY2021Q4 myo Professional Fees Accrued Current
ProfessionalFeesAccruedCurrent
108417
CY2022Q3 myo Deferred Payroll Taxes Under Cares Act
DeferredPayrollTaxesUnderCARESAct
113423
CY2021Q4 myo Deferred Payroll Taxes Under Cares Act
DeferredPayrollTaxesUnderCARESAct
113423
CY2022Q3 myo Accrued Liabilities Customer Deposit
AccruedLiabilitiesCustomerDeposit
715100
CY2021Q4 myo Accrued Liabilities Customer Deposit
AccruedLiabilitiesCustomerDeposit
192501
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
471545
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
446941
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
3649085
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
3949784
CY2022Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2021Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1700
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1700
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1.1718
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0168
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.92
CY2022Q3 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
0
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
0
CY2021Q3 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
0
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
0
CY2022Q3 us-gaap Lease Cost
LeaseCost
125650
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
305633
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
301763
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
917126
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
831046
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
25900
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
112900
us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
The Company has a non-cancelable sublease agreement for its corporate headquarters in Boston, MA expiring in 2023. In conjunction with entering into a non-cancelable lease agreement for its manufacturing space in Boston, the Company agreed to enter into a lease for its corporate headquarters, which together with its leased office space in Fort Worth, TX, both expire in 2025. The Fort Worth, TX, lease has the option to terminate early, which is available at the company’s discretion in 2023. Termination options were not included in the lease term for the Company’s existing operating leases. Certain arrangements have discounted rent periods or escalating rent payment provisions. Leases with an initial term of twelve months or less are not recorded on the consolidated balance sheets. We recognize rent expense on a straight-line basis over the lease term.
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
604960
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
137812
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
411142
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
159872
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
67981
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
776807
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
114520
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
662287
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
441386
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
220901
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
662287
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
125650
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
100835
us-gaap Operating Lease Cost
OperatingLeaseCost
367554
us-gaap Operating Lease Cost
OperatingLeaseCost
271307
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1950
us-gaap Short Term Lease Cost
ShortTermLeaseCost
3250
us-gaap Short Term Lease Cost
ShortTermLeaseCost
27809
CY2021Q3 us-gaap Lease Cost
LeaseCost
102785
us-gaap Lease Cost
LeaseCost
370804
us-gaap Lease Cost
LeaseCost
299116
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M24D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.20

Files In Submission

Name View Source Status
0000950170-22-024522-index-headers.html Edgar Link pending
0000950170-22-024522-index.html Edgar Link pending
0000950170-22-024522.txt Edgar Link pending
0000950170-22-024522-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
myo-20220930.htm Edgar Link pending
myo-20220930.xsd Edgar Link pending
myo-ex31_1.htm Edgar Link pending
myo-ex31_2.htm Edgar Link pending
myo-ex32_1.htm Edgar Link pending
myo-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
myo-20220930_def.xml Edgar Link unprocessable
myo-20220930_lab.xml Edgar Link unprocessable
myo-20220930_pre.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
myo-20220930_htm.xml Edgar Link completed
myo-20220930_cal.xml Edgar Link unprocessable